Cva Family Office, LLC Bristol Myers Squibb CO Transaction History
Cva Family Office, LLC
- $619 Million
- Q4 2024
A detailed history of Cva Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cva Family Office, LLC holds 9,409 shares of BMY stock, worth $556,448. This represents 0.09% of its overall portfolio holdings.
Number of Shares
9,409
Previous 8,724
7.85%
Holding current value
$556,448
Previous $451,000
17.96%
% of portfolio
0.09%
Previous 0.07%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,561Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.2 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.49 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.61 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.61 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $126B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...